What is more, we also found larger areas of necrosis inside the tumor mass in IFN-MSC-treated mice than in other groups which implies that the efficacy of IFN-MSC treatment was not simply displayed through or judged on the visual appearance of the tumor mass. This evidence concerns the gene IFNA1 and neoplasm.